US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 15.140
  • -3.060-16.81%
Close Jul 18 16:00 ET
  • 15.400
  • +0.260+1.72%
Post 19:59 ET
782.79MMarket Cap-6415P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

4D Molecular Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

28.00K

-90.60%
EPS(YoY)

-0.66

+25.00%
Analyst Rating

Strong Buy

Jul 18, 2024

4D Molecular Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 735.710K--
--2024/Q2-- / 685.710K--
--2024/Q128.000K / 915.710K--
--2023/Q4-19.000K / 2.400M--
--2023/Q320.204M / 9.219M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 735.710K--
--2024/Q2-- / 685.710K--
--2024/Q128.000K / 915.710K--
--2023/Q4-19.000K / 2.400M--
--2023/Q320.204M / 9.219M--

Unlock Free Earnings Estimates

4D Molecular Therapeutics Earnings Reports

  • 4D Molecular Therapeutics | 10-Q: Quarterly report

    May 9 16:18 ET

  • 4D Molecular Therapeutics | 10-K: Annual report

    Feb 29 22:33 ET

  • 4D Molecular Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:20 ET

  • 4D Molecular Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 18, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg